The 2019 Hash Bash was Quite a Success!
Being the first year with legal cannabis and sunny weather in the low 70’s, the turn out was tremendous. Scheduled for noon on the diag of University of Michigan’s campus, everyone was in a celebratory mood. There were NO police, even though the public school’s campus is considered Federal property.
Ann Arbor, Mi. area medical dispensaries and head shops were crazy busy this past Saturday!
Check Out the Hash Bash Crowd!
Check out this view of the stage from the middle of the crowd!
There were Plenty of Politicians Speaking
Congresswoman Debbie Dingell, representing Ann Arbor, spoke with passion about expungement.
Debbie Dingell Speaking
State Senator Jeff Irwin, representing Ann Arbor, spoke about the legal cannabis win.
State Representative Yousef Rabhi, spoke late in the program and is always on our side.
Plus, plenty of local politicians not speaking, schmoozing the crowd.
Women in Cannabis
Emma Chasen is a cannabis educator, consultant, and trainer.
Anqunette Jamison Sarfoh, former TV News Anchor turned cannabis activist, after an MS diagnosis.
Sam Pernick, Chair of the Young Democrats of Michigan, is a long-time activist.
Matt Abel, Executive Director of Michigan NORML, long-time Detroit area cannabis attorney and activist.
[Canniseur: Finally! Florida medical cannabis patients can smoke. The will of the voters is finally being upheld.]
After a landslide vote of 101-11 this week in the Florida House SB 182 gets signed into law today by Governor Ron DeSantis at 2:40 PM
Gary Stein of Clarity PAC and other sources in Tallahassee, confirmed that Florida Governor Ron DeSantis signed SB 182 into law today at 2:40PM. This can be confirmed according to a Florida 1st District Court of Appeals filing, Govoner Ron DeSantis has signed SB 182 into law. The repeal of the smoking ban on medical marijuana is now official.
Earlier this year DeSantis put a deadline on this process himself by pressuring the legislature into establishing legal verbiage by March 15, the start of the legislative session. SB 182 will be the first bill of this session to be reviewed at the Governor’s desk.
This bill not only repeals the smoking ban that had been deadlocked by a state appeal, but it also allows doctors to order a 210-day supply of medical cannabis (opposed to the current 70-day limit). Other stipulations include submitting oneself for a data study on the effects of smoking marijuana, but also requires minors (under the age of 18) to be diagnosed with a terminal condition and get a second opinion from their primary pediatrician (or a secondary pediatrician) before receiving the prescription.
DeSantis commended the Legislature for their efforts via Twitter saying, “I thank the Florida Legislature for taking action on medical marijuana and upholding the will of the voters”, but until this signing had not released a formal statement. Having only 3 months in office, his administration is moving at a record pace.
House Speaker Jose Oliva commented after the vote earlier this week, “This is a difficult issue, and you’re going to have people on both sides; some that are happy that now this is available to them and others that feel that we didn’t go far enough,” adding “We did the best that we could do and still remain responsible.”
Read the rest of the article here: Florida Governor Ron DeSantis Officially Ends The Ban on Smokable Medical Marijuana – Canna Chronicle
In January of 2019, WHO recommended the rescheduling of cannabis. The U.S. is preparing to address rescheduling of cannabis at the upcoming United Nations Commission on Narcotic Drugs (CND) meeting.
The U.S. Food and Drug Administration Agency has opened up a short comment period intended to bring the public’s voice into their decision process. Lowell J. Schiller, Acting Associate Commissioner for Policy, posted Feb 25, 2019 a request for those interested in submitting comments about the World Health Organization (WHO) recommendations.
Presumably, your comments are meant to inform U.S. policy ahead of the March 18-22 meeting of the United Nations CND in Vienna, Austria. Electronic comments must be submitted on or before March 14, 2019.
If interested in commenting, please visit Regulations.gov.
Many people looking to improve the quality of their life have turned to CBD supplements to reduce pain and symptoms related to stress. Plus CBD can help improve many other health conditions. With the recent Federal legalization of hemp and the legalization of cannabis in 10 States plus DC, CBD is coming into its own.
Canniseur had the opportunity to meet one of the leaders in the CBD industry, Anthony Walsh. Anthony is a serial entrepreneur and the founder of EcoLife Premium Hemp Extracts who wants to make a difference in the world.
Interview: EcoLife Premium Hemp Extracts, Anthony Walsh
Canniseur: The first thing I’d like you to share with our readers is your story. You’ve been a very successful entrepreneur in past ventures. We’d love to hear your motivation for entering the cannabis/CBD field.
Anthony: My business successes came at the price of my health. I started taking CBD due to trouble sleeping and stress and anxiety from my running my storm restoration company DuraShield Contracting. In my research on how to improve one’s health, I found certain life style changes can improve one’s over all well-being. I changed my diet and increased my exercise. Around that time I discovered CBD. I tried it and found great relief. The CBD I found was made in small batches. It worked great. My father became ill and I had him try it. It helped him a great deal too. Then there was a friend who asked about it. Then another. Soon, many family members and friends were getting their CBD oil from me. It really snowballed from there.
My research on CBD found quality control to be lacking. There was no easy way to understand the quality and difference of one CBD product from another. No one was testing their product and making that information available. I was sure I could do this better.
I’ve found a great, organic source of hemp, and a processor that would work with me on the exceptional standards I demand. I want to sell to the public only a product that I would take myself or give to my family.
C: What exactly is the EcoLife movement?
A: The EcoLife Movement is a growing health movement of people living healthier and for more filling lives by using a quality cannabinoid rich hemp supplement like EcoLife daily
C: You’ve invested heavily in the legal and regulatory landscape of “Full Spectrum” products, please tell us what your motivation was for this.
A: At EcoLife want our products to be exactly as we say it is. We want to ensure the quality of our products so our customers know exactly what they are ingesting. It’s as important to me to use only high quality products as it is to sell only the highest quality products. To this end, we invest in regular, 3rd party lab testing to certify our CBD products have the full spectrum of cannabinoids and nothing else. It’s not cheap to have certified lab testing for our products, but this is our utmost priority.
C: While acknowledging that CBD use is becoming more mainstream, there is still has some stigma attached. It’s the scary reefer madness afterglow. Are you planning any educational outreach?
A: We are continually engaging in education. We sing the rewards of good quality full spectrum CBD oil. So, yes our educational efforts will continue.
C: Assuming federal legalization, what is your plan for growing your business before vs. after legalization occurs?
A: Great question. We do plan, down the road, to expand into high THC products. For now though we plan on continuing to sell high quality, certified CBD full spectrum oils, made with sustainably grown, organic hemp. Our CBD full spectrum oil is manufactured with incredibly tight controls.
Our sales have been growing organically as well. We have done very little marketing, yet our sales are doing better than we could have ever expected.
C: Are there different ‘recipes’ for different CBD FSO supplements? Or are they all the same and considered a general health aid for overall better health?
A: This question goes to the heart of how CBD is made and works. The specific cannabinoids found in one full spectrum oil brand is different from another manufacturer. This is solely based on the genetic make up of the hemp plant being grown and processed. All hemp plants are not created equal and the have different genetic makeups. The result is the CBD from one field of hemp is bound to have a different ratio of terpenes and other cannabinoids. The strain of the hemp we process has a high CBD content. It’s this that set us apart from our competitor’s FSO.
C: Are your products available in stores? Where?
A: Our products are available in several stores throughout Wisconsin and a handful of stores in other states like California and South Carolina. You can also purchase our products online at our website.
[Editor’s Note: The news is starting to come in from DAVOS on the business of cannabis. If you’re an investor, this is of interest.]
The Cannabis Business is Booming — But that’s not Necessarily Good if You’re an Investor
- Everybody wants to be in the cannabis space and I think Investors have to be selective because … there will be a new name every week,” the CEO of a pot growing company said.
- Last week, William Barr, President Trump’s nominee to lead the U.S. Justice Department, said Congress needs to come up with a plan to overcome the discrepancies between state and federal law.
The pot industry faces a “massive inflationary bubble,” and that means investors have to be careful, a cannabis CEO told CNBC at the World Economic Forum in Davos, Switzerland.
“Many, many people are entering the cannabis space, which is terrific, but they actually have to have a purpose — they should be able to generate a business,” said Bruce Linton, chief of Canada-based Canopy Growth.
“Everybody wants to be in the cannabis space, and I think investors have to be selective because … there will be a new name every week,” Linton warned.
The legalization of cannabis for recreational use in Canada last year boosted interest in the industry. Some U.S. states have also approved the use of cannabis. Utah and Missouri approved the use of marijuana for medical purposes in November, while Michigan gave the green light to its recreational use.
Richard Carleton, chief executive officer of Canadian Securities Exchange (CSE), told CNBC it’s only a matter of time until the United States approves cannabis at the federal level.
It is a matter of “two and half or six and half years, it depends on the presidential cycle,” he said.
Last week, William Barr, who is President Donald Trump’s nominee to lead the U.S. Justice Department, said Congress needs to come up with a plan to overcome the discrepancies between state and federal law. Barr said he is personally against pot, but he opposes a reversal by the former attorney general against a policy that eased federal enforcement of marijuana laws.
The uncertainty about where the U.S. will go will bring volatility to cannabis stocks, according to the CEO of the financial services firm Canaccord Genuity.
“The U.S. — who knows what’s going to happen? Tons of good things could happen, tons of bad news could happen. Therefore you will continue to see a lot of volatility,” Daniel Daviau said.
“Here you’re measuring earnings two years out, and you’re putting a relatively large multiple on that. You don’t need much of a change in attitude to shift the stock price, so you will see a lot of volatility,” he added.
‘Great Opportunity’ in the Next Markets
There are upcoming markets for the cannabis industry, including Israel and European countries. According to Daviau from Canaccord Genuity, “Europe is gonna go nice and slow.”
Ultimately, he said, it’s a “great opportunity, but years in the making.”
Linton recalled: “Who’s got federal legalization on the books? Greece, Germany, England, Denmark, Czech Republic — they are all federally regulated for medical access.”
The three interviewees agreed that the future of cannabis will come from the medical side, which will subsequently open the doors to wider recreational uses.
“If we reconvene in five years, the proportion which is smoked will be a very small fraction,” Linton said.
“And that’s because medical” will create better product, he added, citing the hypothetical example of anti-anxiety beverages that could be tested medically and then be sold as a way for people to be socially active with greater ease.
Original Article: Pot business: A cannabis industry bubble creates investing challenges, CNBC
Photo: Tom Franck | CNBC
Canopy Growth operations in Smiths Falls, Ontario.